Flu vaccine effectiveness: A metaanalysis;Efectividad de la vacuna contra influenza: Metanálisis de literatura

Biomedica

Volumn 29, Issue 1, 2009, Pages 87-97

  Moreno, José ^a   De la Hoz, Fernando ^a   Rico, Alejandro ^a   Cotes, Karol ^a   Porras, Alexandra ^a  

^a INSTITUTO NACIONAL DE SALUD   (Colombia)

Author keywords

Effectiveness; Efficacy; Influenza vaccines; Meta analysis

Indexed keywords

FLU VACCINE;

INFLUENZA VACCINE;

AGE; AGED; CASE CONTROL STUDY; COHORT ANALYSIS; EVALUATION; FEMALE; HOSPITALIZATION; HUMAN; INFANT; INFLUENZA; MALE; META ANALYSIS; REVIEW; STATISTICS;

AGE FACTORS; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; EVALUATION STUDIES AS TOPIC; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE;

EID: 70350452435     PISSN: 01204157     EISSN: None     Source Type: Journal    
DOI: 10.7705/biomedica.v29i1.44     Document Type: Article

References (29)

1. Organización Mundial de la Salud. Vacunas contra la influenza. Boletín Epidemiológico Semanal. 2005;80:279- 28.
2. Dirección General de Salud Pública, Grupo de Vigilancia en Salud Pública, Ministerio de la Protección Social. La influenza y su situación en Colombia. Bogotá D.C.: Ministerio de la Protección Social; 2005.
3. Abarca K. Influenza: vacunación a nuevos grupos etarios. Rev Chil Infect. 2007;24:227-30.
4. Bridges CB, Harper SA, Fukuda K, Uyeki T M, Cox NJ , Singleton JA. Prevention and control of influenza. Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2003;52:1-34.
5. World Health Organization. Guidelines on the use of vaccines and antiviral during influenza pandemics. Ginebra: WHO; 2004.
6. Woolacott N. Systematic review protocol. Center for Reviews and Dissemination, University of York. York, UK: University Press; 2006.
7. The Cochrane Collaborative Review Group on HIV Infection and AIDS. Inclusion and appraisal of experimental and non-experimental (observational) studies. Washington, D.C.: John Wiley & Sons; 2007.
8. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised consort statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663-94.
9. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale for assessing the quality of non randomized studies in metaanalyses. Leicester, UK: University of Ottawa Press; 2007.
10. Moreno J, De la Hoz F. Protocolo de revisión sistemática de literatura (documento institucional). Bogotá D.C.: Instituto Nacional de Salud; 2007.
11. Salanti G, Sanderson S, Higgins P. Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med. 2005;7:11-3.
12. Egger M, Davey G, Phillips AN. Meta-analysis: principles and procedures. BMJ. 1997;315:1533-7.
13. Berlin JA. Invited commentary. Am J Epidemiol. 1995;142:383-7.
14. Frumkin H, Berlin J. Asbestos exposure and gastrointestinal malignancy review and meta-analysis. Am J Ind Med. 1988;14:79-95.
15. Cook TD, Cooper H, Cordray DS, Hartmann H, Hedges LV, Light RJ, et al. Meta-analysis for explanation: a casebook. New York: Russell Sage Foundation; 1992.
16. The Nordic Cochrane Centre. Review Manager (RevMan) [Computer program]. Version 4.2 for Windows. Copenhagen: The Cochrane Collaboration; 2003.
17. StataCorp LP .Stata 9.0 [Computer program]. Version 9.0 for Windows. College Station, TX: StataCorp LP; 2006.
18. Dott MM. Come distruggere in maniera scientifica il sistema immunitario, con i vaccini. Danni biologici dei vaccini e cure. Med J Aust. 2001;154:638.
19. Colquhoun AJ, Nicholson KG, Botha JL, Raymond NT. Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes. Epidemiol Infect. 1997,119:335-41.
20. Ahmed AH, Nicholson KG, Nguyen-Van JS, Pearson JC. Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic. Epidemiol Infect. 1997;118:27-33.
21. Ahmed AH, Nicholson KG, Nguyen-Van JS. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet. 2001;126:71-9.
22. Megumi H, Tatsuhiko S, Keitaro T. Effectiveness of influenza vaccination in preventing influenza-like illness among community-dwelling elderly: population-based cohort study in Japan. Vaccine. 2006;24:5546-51.
23. Nichol K, Baken L, Worenma J. The health and economics benefits associated with pneumococcal vacination of elderly persons with chronic lung disease. Arch Intern Med. 1999;8:2437-42.
24. Moher D, Fortin P, Jadad AR. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet. 1996;347:363-76.
25. Belshe R, Kathryn E, Vlack S, Walker R, Hultquist M, Connor G, et al. Live attenuated versus inactivated vaccine in infants and young children. N Eng J Med. 2007;356:685-96.
26. Mesa SS, Moreno AP, Hurtado G, Arbeláez MP. Efectividad de una vacuna antigripal en una población laboral colombiana. Rev Panam Salud Pública. 2001;10:35-9.
27. The Cochrane Collaboration. Eficacia y efectividad de las vacunas contra la influenza en adultos mayores. Rev Panam Salud Pública. 2005;18 447.
28. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
29. Organización Mundial de la Salud. Declaración sobre la calidad de las vacunas. Declaración de política general del Programa Mundial de Vacunas y Vacunación. Ginebra: OMS; 1997.